Vasopressor resident survival guide

Jump to navigation Jump to search

Sepsis Microchapters

Home

Patient Information (Adult)

Patient Information (Neonatal)

Overview

Pathophysiology

Causes

Differentiating Sepsis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vasopressor resident survival guide On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Vasopressor resident survival guide

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Vasopressor resident survival guide

CDC on Vasopressor resident survival guide

Vasopressor resident survival guide in the news

Blogs on Vasopressor resident survival guide

Directions to Hospitals Treating Sepsis

Risk calculators and risk factors for Vasopressor resident survival guide

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Definition

Causes

Life Threatening Causes

Common Causes

Prognosis

Management

 
 
 
 
 
 
 
 
 
 
 
 
Vasopressors
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Norepinephrine
 
Dopamine
 
Vasopressin
 
Phenylephrine
 
Dobutamine
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mechanism
 
*Mainly α1 (Vasoconstrictive)
*β1 (↑contractility)
 
*Mainly β1 (↑contractility)
*α1(Vasoconstrictive)
 
*V1 receptor of GIT vasculatures
*Antidiuretic effects
 
*Pure α1 (Vasoconstrictive)
*No β1
 
*Mainly β1 (↑contractility)
*β2 arterial smooth muscle (Hypotensive)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Indication
 
*1st line Septic shock
*1st line Cardiogenic shock
*Undifferentiated shock
 
2nd line septic shock
 
2nd line septic shock
 
1st line Neurogenic shock
3rd-4th line septic shock
 
*1st line cardiogenic shock
* low output septic shock
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dose
 
1-30 mcg/kg/min
 
1-20 mcg/min
 
0.03 unit/min
 
20-300 mcg/kg/min
 
2.5-20 mcg/kg/min
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Complications
 
Less tachyarrhythmia than Dopamine
 
Arrhythmia (β1)
 
*Coronary spasm
*Splanchnic vasoconstriction
 
Reflex bradycardia
No worsening of Tachycardia (only α1)
 
Hypotension (β2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cautions
 
Arrhythmia
 
*Not in cardiogenic shock
*Arrhythmia
*cardiotoxicity with ischemia
 
*Ischemic heart(Troponin > 10)
*Gut ischemia
 
 
If hypotension, add α1 agonist
 

Do's

  • Assess the cause of shock
  • Always volume fluid resuscitation first
  • Norepinephrine in undifferentiated shock.

Don'ts

References

Template:WH Template:WS